Overnight Fasting Before Lapatinib Administration to Breast Cancer Patients Leads to Reduced Toxicity
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Cancer Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Overnight Fasting Before Lapatinib Administration to Breast Cancer Patients Leads to Reduced Toxicity Compared With Nighttime Dosing: A Retrospective Cohort Study From a Randomized Clinical Trial
Cancer Med 2020 Oct 23;[EPub Ahead of Print], M Tsuda, H Ishiguro, N Toriguchi, N Masuda, H Bando, M Ohgami, M Homma, S Morita, N Yamamoto, K Kuroi, Y Yanagita, T Takano, S Shimizu, M ToiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.